These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30728065)

  • 1. Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin.
    Johnson ME; Franks JM; Cai G; Mehta BK; Wood TA; Archambault K; Pioli PA; Simms RW; Orzechowski N; Arron S; Whitfield ML
    Arthritis Res Ther; 2019 Feb; 21(1):49. PubMed ID: 30728065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease.
    Andréasson K; Alrawi Z; Persson A; Jönsson G; Marsal J
    Arthritis Res Ther; 2016 Nov; 18(1):278. PubMed ID: 27894337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis.
    Langan EA; Künstner A; Miodovnik M; Zillikens D; Thaçi D; Baines JF; Ibrahim SM; Solbach W; Knobloch JK
    Br J Dermatol; 2019 Dec; 181(6):1254-1264. PubMed ID: 30985920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory multi-omics analysis reveals host-microbe interactions associated with disease severity in psoriatic skin.
    Yang Y; Olah P; Radai Z; Maia G; Salava A; Salo V; Barker J; Lauerma A; Andersson B; Homey B; Fyhrquist N; Alenius H
    EBioMedicine; 2024 Jul; 105():105222. PubMed ID: 38924840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus.
    Bjerre RD; Holm JB; Palleja A; Sølberg J; Skov L; Johansen JD
    BMC Microbiol; 2021 Sep; 21(1):256. PubMed ID: 34551705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.
    Plichta DR; Somani J; Pichaud M; Wallace ZS; Fernandes AD; Perugino CA; Lähdesmäki H; Stone JH; Vlamakis H; Chung DC; Khanna D; Pillai S; Xavier RJ
    Genome Med; 2021 Feb; 13(1):35. PubMed ID: 33648559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-Life Antibiotic Exposure Causes Intestinal Dysbiosis and Exacerbates Skin and Lung Pathology in Experimental Systemic Sclerosis.
    Mehta H; Goulet PO; Mashiko S; Desjardins J; Pérez G; Koenig M; Senécal JL; Constante M; Santos MM; Sarfati M
    J Invest Dermatol; 2017 Nov; 137(11):2316-2325. PubMed ID: 28757138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome profiling in systemic sclerosis: a metagenomic approach.
    Tan TC; Chandrasekaran L; Leung YY; Purbojati R; Pettersson S; Low AHL
    Clin Exp Rheumatol; 2023 Aug; 41(8):1578-1588. PubMed ID: 36826808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome as an Immunological Modifier.
    Kumar M; Singh P; Murugesan S; Vetizou M; McCulloch J; Badger JH; Trinchieri G; Al Khodor S
    Methods Mol Biol; 2020; 2055():595-638. PubMed ID: 31502171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects.
    Ganju P; Nagpal S; Mohammed MH; Nishal Kumar P; Pandey R; Natarajan VT; Mande SS; Gokhale RS
    Sci Rep; 2016 Jan; 6():18761. PubMed ID: 26758568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis.
    Denton CP; Murray C
    Arthritis Res Ther; 2019 Mar; 21(1):81. PubMed ID: 30917857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.
    Derrett-Smith EC; Martyanov V; Chighizola CB; Moinzadeh P; Campochiaro C; Khan K; Wood TA; Meroni PL; Abraham DJ; Ong VH; Lafyatis R; Whitfield ML; Denton CP
    Arthritis Res Ther; 2017 Jul; 19(1):156. PubMed ID: 28676069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving approaches to profiling the microbiome in skin disease.
    Chen Y; Knight R; Gallo RL
    Front Immunol; 2023; 14():1151527. PubMed ID: 37081873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.
    Avouac J; Cagnard N; Distler JH; Schoindre Y; Ruiz B; Couraud PO; Uzan G; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2011 Nov; 63(11):3552-62. PubMed ID: 21769840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
    Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
    Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.
    Teaw S; Hinchcliff M; Cheng M
    Rheumatology (Oxford); 2021 Dec; 60(12):5498-5508. PubMed ID: 33734316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life on human surfaces: skin metagenomics.
    Mathieu A; Delmont TO; Vogel TM; Robe P; Nalin R; Simonet P
    PLoS One; 2013; 8(6):e65288. PubMed ID: 23776466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin.
    Apostolidis SA; Stifano G; Tabib T; Rice LM; Morse CM; Kahaleh B; Lafyatis R
    Front Immunol; 2018; 9():2191. PubMed ID: 30327649
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbe-host interplay in atopic dermatitis and psoriasis.
    Fyhrquist N; Muirhead G; Prast-Nielsen S; Jeanmougin M; Olah P; Skoog T; Jules-Clement G; Feld M; Barrientos-Somarribas M; Sinkko H; van den Bogaard EH; Zeeuwen PLJM; Rikken G; Schalkwijk J; Niehues H; Däubener W; Eller SK; Alexander H; Pennino D; Suomela S; Tessas I; Lybeck E; Baran AM; Darban H; Gangwar RS; Gerstel U; Jahn K; Karisola P; Yan L; Hansmann B; Katayama S; Meller S; Bylesjö M; Hupé P; Levi-Schaffer F; Greco D; Ranki A; Schröder JM; Barker J; Kere J; Tsoka S; Lauerma A; Soumelis V; Nestle FO; Homey B; Andersson B; Alenius H
    Nat Commun; 2019 Oct; 10(1):4703. PubMed ID: 31619666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
    Affandi AJ; Carvalheiro T; Ottria A; Broen JC; Bossini-Castillo L; Tieland RG; Bon LV; Chouri E; Rossato M; Mertens JS; Garcia S; Pandit A; de Kroon LM; Christmann RB; Martin J; van Roon JA; Radstake TR; Marut W
    Ann Rheum Dis; 2019 Sep; 78(9):1249-1259. PubMed ID: 31126957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.